Suchergebnisse - "Shiina, Tomohiko"

PubPharm (36)

1

Real-world effectiveness of erenumab in Japanese patients with migraine

enthalten in: Heliyon | 2024

von Suzuki, K. | Suzuki, S. | Shiina, T. | +4

2

Impact of autonomic symptoms on the clinical course of Parkinson's disease

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2024

von Fujita, H. | Ogaki, K. | Shiina, T. | +3

3

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule

enthalten in: Journal of the neurological sciences | 2023

von Suzuki, S. | Suzuki, K. | Shiina, T. | +3

CommentOn: J Neurol Sci. 2023 Oct 15;453:120811. - PMID 37757639

4

Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease

enthalten in: Journal of the neurological sciences | 2023

von Ogaki, K. | Fujita, H. | Nozawa, N. | +3

5

Impact of autonomic symptoms on the clinical course of Parkinson’s disease

enthalten in: ResearchSquare.com | 2023

von Fujita, H. | Ogaki, K. | Shiina, T. | +3

6

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

enthalten in: Journal of neurology | 2023

von Suzuki, K. | Suzuki, S. | Shiina, T. | +4

7

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

enthalten in: Journal of neurology | 2023

von Suzuki, K. | Suzuki, S. | Shiina, T. | +4

8

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

enthalten in: Journal of neurology | 2023

von Suzuki, K. | Suzuki, S. | Shiina, T. | +4

9

Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine : A 12-month, single-center, observational real-world study in Japan

enthalten in: Cephalalgia : an international journal of headache | 2023

von Suzuki, K. | Suzuki, S. | Shiina, T. | +4

10

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan

enthalten in: Frontiers in neurology | 2023

von Suzuki, S. | Suzuki, K. | Shiina, T. | +2